88 related articles for article (PubMed ID: 4273935)
1. Decrease of muscle rigidity by dimethylaminoadamantan (DMMA) in intercollicularly decerebrated cats.
Sontag KH; Wand P
Arzneimittelforschung; 1973 Dec; 23(12):1737-9. PubMed ID: 4273935
[No Abstract] [Full Text] [Related]
2. A comparison of the actions of some drugs on decerebrate rigidity, muscle spindle activity and alpha-adrenoceptors.
Maxwell DR; Sumpter EA
Br J Pharmacol; 1974 Mar; 50(3):355-63. PubMed ID: 4277330
[TBL] [Abstract][Full Text] [Related]
3. Sustained firing of alpha and gamma hind limb motoneurons induced by stimulation of the pudendal nerve.
Cueva-Rolón R; Delgado-Lezama R; Raya JG; Raya M; Tecuanhuey R; Muñoz-Martínez EJ
J Neurophysiol; 2002 Dec; 88(6):3232-42. PubMed ID: 12466443
[TBL] [Abstract][Full Text] [Related]
4. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex.
Meyer M; Adorjáni C
Adv Neurol; 1983; 39():997-1011. PubMed ID: 6660131
[No Abstract] [Full Text] [Related]
5. [Electromyographic analysis of the mechanism governing the action of curare-like agents].
Fisenko VP
Farmakol Toksikol; 1972; 35(3):284-7. PubMed ID: 4340074
[No Abstract] [Full Text] [Related]
6. [The interaction between adrenaline and amantadine on isolated spleen (author's transl)].
Mundo-Salvador A
Rev Esp Fisiol; 1972 Dec; 28(4):261-4. PubMed ID: 4680085
[No Abstract] [Full Text] [Related]
7. Suppression of decerebrate rigidity by phenytoin and chlorpromazine.
Anderson RJ; Raines A
Neurology; 1976 Sep; 26(9):858-62. PubMed ID: 133301
[TBL] [Abstract][Full Text] [Related]
8. [Search for new antidepolarizing muscle relaxants and the 1st experience with their clinical use].
Vanevskiĭ VL; Danilov AF; Kotomina GL; Malygin VV; Starshinova LA
Anesteziol Reanimatol; 1978; (4):36-8. PubMed ID: 151518
[No Abstract] [Full Text] [Related]
9. Inhibition of vestibular and neck reflexes in forelimb extensor muscles during the episodes of postural atonia induced by an anticholinesterase in decerebrate cat.
Manzoni D; Pompeiano O; Srivastava UC; Stampacchia G
Arch Ital Biol; 1983 Dec; 121(4):267-83. PubMed ID: 6609688
[TBL] [Abstract][Full Text] [Related]
10. [The effect of adamantyl radicals on the mechanism of the cholinergic action of mono-quaternary ammonium compounds].
Kharkevich DA; Skoldinov AP; Ibadova DN
Farmakol Toksikol; 1973; 36(2):201-5. PubMed ID: 4275569
[No Abstract] [Full Text] [Related]
11. [The effect of adamantyl radicals on the mechanism of the cholinergic action of mono-quaternary ammonium compounds].
Kharkevich DA; Skoldinov AP; Ibadova DN
Farmakol Toksikol; 1973; 36(2):201-5. PubMed ID: 4275568
[No Abstract] [Full Text] [Related]
12. Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegmental nucleus and the substantia nigra pars reticulata in decerebrate cats.
Takakusaki K; Saitoh K; Harada H; Okumura T; Sakamoto T
Neuroscience; 2004; 124(1):207-20. PubMed ID: 14960352
[TBL] [Abstract][Full Text] [Related]
13. Dimethothiazine in spasticity. A further attempt at pharmacological control.
Matthews WB; Rushworth G; Wakefield GS
Acta Neurol Scand; 1972; 48(5):635-44. PubMed ID: 4643259
[No Abstract] [Full Text] [Related]
14. The depression of monosynaptically excited alpha-motoneurons during vibration reflex by dimethylaminoadamantan (DMAA).
Mühlberg B; Sontag KH
Naunyn Schmiedebergs Arch Pharmacol; 1973; 280(1):113-6. PubMed ID: 4273668
[No Abstract] [Full Text] [Related]
15. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats.
Matsunaga M; Uemura Y; Yonemoto Y; Kanai K; Etoh H; Tanaka S; Atsuta Y; Nishizawa Y; Yamanishi Y
Jpn J Pharmacol; 1997 Mar; 73(3):215-20. PubMed ID: 9127816
[TBL] [Abstract][Full Text] [Related]
16. Drug treatment of spasticity and rigidity.
Calne DB
Mod Trends Neurol; 1975; 6():205-21. PubMed ID: 1105140
[No Abstract] [Full Text] [Related]
17. Pharmacology of M & B 18,706, a drug which selectively reduces decerebrate rigidity.
Maxwell DR; Read MA; Sumpter EA
Br J Pharmacol; 1974 Jan; 50(1):35-45. PubMed ID: 4150889
[TBL] [Abstract][Full Text] [Related]
18. On the sites of antitsive action of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3).
Kasé Y; Wakita Y; Yuizono T; Kito G; Kikuchi K
Arzneimittelforschung; 1970 Jan; 20(1):37-43. PubMed ID: 5467446
[No Abstract] [Full Text] [Related]
19. The development of animal models for studies in Parkinson's disease.
Poirier LJ
Contemp Neurol Ser; 1971; 8():83-117. PubMed ID: 5005690
[No Abstract] [Full Text] [Related]
20. [Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)].
Gehlen W; Eisenlohr JJ
Nervenarzt; 1974 Jan; 45(2):22-9. PubMed ID: 4601993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
